Literature DB >> 15516540

Antibiotic rotation and development of gram-negative antibiotic resistance.

Harald J van Loon1, Menno R Vriens, Ad C Fluit, Annet Troelstra, Christiaan van der Werken, Jan Verhoef, Marc J M Bonten.   

Abstract

To attain a better understanding of antibiotic cycling and its effects on the epidemiology of antibiotic resistance in gram-negative microorganisms, two different antibiotic classes (quinolone and beta-lactam) were cycled during four 4-month periods in a surgical intensive care unit. Respiratory aspirates and rectal swabs were obtained and DNA fingerprinting was performed. Primary endpoint of the study was the acquisition rate with gram-negative bacteria resistant to the antibiotic of choice during each cycle. Secondary endpoints were changes in endemic prevalence of resistant bacteria and the relative importance of cross-transmission. In all, 388 patients were included and 2,520 cultures analyzed. Adherence to antibiotic protocol was 96%. Overall antibiotic use increased with 24%. Acquisition rates with resistant bacteria were highest during levofloxacin exposure (relative risk [RR] 3.2; 95% confidence interval [CI]: 1.4-7.1) and piperacillin/tazobactam exposure (RR 2.4; 95% CI 1.2-4.8). The relative importance of cross-transmission decreased during the study. For individual patients, treatment with levofloxacin was the only independent risk factor for acquisition of levofloxacin-resistant bacteria (hazard ratio 12.6; 95% CI 3.8-41.6). Potential for selection of antibiotic-resistant gram-negative bacteria during periods of homogeneous exposure increased from cefpirome to piperacillin/tazobactam to levofloxacin. Cycling of homogeneous antibiotic exposure is unlikely to control the emergence of gram-negative antimicrobial resistance in intensive care units.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516540     DOI: 10.1164/rccm.200401-070OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  24 in total

1.  Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria.

Authors:  E Raineri; L Crema; S Dal Zoppo; A Acquarolo; A Pan; G Carnevale; F Albertario; A Candiani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

2.  [Infection-inflammation-sepsis: state of the art and future perspectives. Tübingen Intensive Symposium, 08.10.2005].

Authors:  F Schröder; W A Krueger
Journal:  Anaesthesist       Date:  2006-07       Impact factor: 1.041

3.  Selection of resistance during sequential use of preferential antibiotic classes.

Authors:  Pierre Damas; Jean-Luc Canivet; Didier Ledoux; Mehran Monchi; Pierrette Melin; Monique Nys; Patrick De Mol
Journal:  Intensive Care Med       Date:  2005-11-25       Impact factor: 17.440

4.  Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance.

Authors:  Stefany Moreno-Gamez; Alison L Hill; Daniel I S Rosenbloom; Dmitri A Petrov; Martin A Nowak; Pleuni S Pennings
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-18       Impact factor: 11.205

Review 5.  Bacterial resistance: a sensitive issue complexity of the challenge and containment strategy in Europe.

Authors:  W T M Jansen; J T van der Bruggen; J Verhoef; A C Fluit
Journal:  Drug Resist Updat       Date:  2006-06-27       Impact factor: 18.500

6.  Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial.

Authors:  Jan J De Waele; S Carrette; M Carlier; V Stove; J Boelens; G Claeys; I Leroux-Roels; E Hoste; P Depuydt; J Decruyenaere; A G Verstraete
Journal:  Intensive Care Med       Date:  2013-12-20       Impact factor: 17.440

7.  A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis.

Authors:  Frank Bloos; Frank Hinder; Karsten Becker; Svea Sachse; Armand Mekontso Dessap; Eberhard Straube; Vincent Cattoir; Christian Brun-Buisson; Konrad Reinhart; Georg Peters; Michael Bauer
Journal:  Intensive Care Med       Date:  2009-11-19       Impact factor: 17.440

8.  Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.

Authors:  Jan J De Waele; J Lipman; M Akova; M Bassetti; G Dimopoulos; M Kaukonen; D Koulenti; C Martin; P Montravers; J Rello; A Rhodes; A A Udy; T Starr; S C Wallis; J A Roberts
Journal:  Intensive Care Med       Date:  2014-07-23       Impact factor: 17.440

9.  Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study.

Authors:  Igor Francetić; Smilja Kalenić; Mirjana Huić; Iveta Mercep; Ksenija Makar-Ausperger; Robert Likić; Viktorija Erdeljić; Vesna Tripković; Petra Simić
Journal:  Croat Med J       Date:  2008-04       Impact factor: 1.351

10.  Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria.

Authors:  Saskia Nijssen; Ad Fluit; David van de Vijver; Janetta Top; Rob Willems; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2010-03       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.